prochlorperazine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Prochlorperazine: A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)
prochlorperazine : A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Otręba, M | 1 |
Kośmider, L | 1 |
Rzepecka-Stojko, A | 1 |
Kow, CS | 1 |
Hasan, SS | 1 |
1 review available for prochlorperazine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review.
Topics: Animals; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Chlorpromazine; Coronavirus Infect | 2020 |
1 other study available for prochlorperazine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Prochlorperazine for nausea and vomiting accompanied COVID-19.
Topics: Antiemetics; COVID-19; Humans; Nausea; Prochlorperazine; Vomiting | 2021 |